60 Degrees Pharmaceuticals, Inc. SXTP 深 沪
等待开盘 03-30 09:30:00 美东时间
1.50
+0.010
+0.67%
华盛通- 最 高1.5299
- 今 开1.46
- 成交量 17.84万股
- 最 低 1.3201
- 昨 收 1.49
- 总市值 193.08万
- 52周最高 17.68
- 市盈率 静 --
- 换手率 13.86%
- 52周最低 1.29
- 委 比 54.84%
- 总股本 128.72万
- 历史最高 2076.00
- 量 比 0.65
- 振 幅 14.08%
- 历史最低 1.3201
- 每 手 1
- 风险率 2.91%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification With FDA For Australian Chestnut Extract; Inks Deal To License Florida State University's Ownership Rights To New Capsule Formulation Methods For Australian Chestnut Extract
60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) ("60 Degrees Pharma" or the "Company"), a pharmaceutical company focused on developing new medicines for vector-borne disease, today announced it submitted a
03-18 20:10
What's Going On With 60 Degrees Pharmaceuticals On Friday?
60 Degrees Pharma shares fall premarket after a huge rally as its babesiosis trial reports a 100% cure rate with tafenoquine treatment.
03-13 21:11
60 Degrees Pharmaceuticals Says All Three Patients Cured Of Babesiosis After Tafenoquine Treatment In Expanded Use Clinical Trial
All three patients enrolled in study have been cured, confirming high cure rate of tafenoquine in immunosuppressed patients, as reported by Yale in a 2024 publicationCompany calls for existing babesiosis treatment
03-11 19:26
60 Degrees Pharma shares are trading lower. The company announced a partnership with GoodRx to offer eligible consumers savings of up to 30% on ARAKODA.
60 Degrees Pharma shares are trading lower. The company announced a partnership...
02-03 03:00
美股大行评级 | 瑞穗上调希捷科技、西部数据、CoreWeave目标价；Trade Desk、W.R. Berkley遭多家大行下调目标价
今日重点评级关注：瑞穗：维持Syndax制药"跑赢大市"评级，目标价从410美元升至600美元；HC Wainwright & Co.：维持60 Degrees Pharmaceuticals, Inc."买入"评级，目标价从6美元升至24美元
01-28 10:59
60 Degrees Pharmaceuticals shares are trading higher after the company announced a partnership with Runway Health to expand pre-departure access to ARAKODA.
60 Degrees Pharmaceuticals shares are trading higher after the company announce...
01-22 21:07
60 Degrees Pharmaceuticals Identifies Babesia Parasite In 24% Of Participants In Group Of 50 Patients With Chronic Fatigue
60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) ("60 Degrees Pharma" or the "Company"), a pharmaceutical company focused on developing new medicines for vector-borne disease, today announced that infection
2025-12-29 21:11
60 Degrees Pharma To Expand ARAKODA Sales And Marketing, Adding Reps, GoodRx Partnership And Enhanced Digital Campaign
6-month commercial pilot demonstrated increasing demand among prescribersExpansion plan includes doubling the number of sales reps, a new GoodRx partnership, and enhanced digital marketing campaignAdditional clinical
2025-12-11 21:19
美股大行评级 | 美银证券下调哔哩哔哩目标价至31美元；高盛下调诺和诺德目标价至54美元
今日重点评级关注：Benchmark：维持Grupo Televisa"买入"评级，目标价从9美元升至10美元；Truist Securities：维持迪尔股份"买入"评级，目标价从609美元升至612美元
2025-12-01 14:33
Ascendiant Capital Maintains Buy on 60 Degrees, Lowers Price Target to $2.8
Ascendiant Capital analyst Lucas Ward maintains 60 Degrees (NASDAQ:SXTP) with a Buy and lowers the price target from $3 to $2.8.
2025-11-28 18:57
